Subscribe
Sign in
Home
Notes
Chat
Archive
Leaderboard
About
Latest
Top
Discussions
COVID Update: COVID Cases Rising Worldwide: Inside the NB.1.8.1 (Nimbus) vs. XFG (Stratus) Variant Battle
New COVID Surge Explained: A Deep Dive into NB.1.8.1 (Nimbus) vs. XFG (Stratus)
Jun 25
•
TACT
19
Share this post
T.A.C.T.
COVID Update: COVID Cases Rising Worldwide: Inside the NB.1.8.1 (Nimbus) vs. XFG (Stratus) Variant Battle
Copy link
Facebook
Email
Notes
More
April 2025
Negligence with Consequences: COVID Is Damaging Kids’ Hearts
Clean Air in Classrooms is a Right - Not a Privilege
Apr 16
•
TACT
52
Share this post
T.A.C.T.
Negligence with Consequences: COVID Is Damaging Kids’ Hearts
Copy link
Facebook
Email
Notes
More
1
COVID Variant Update: LP.8.1 Dominates for Now—But the Next Variant Wave Is Building. A Deep Dive into NB.1.8.1
NB.1.8.1 vs XFG: Which Variant Has the Edge? A Long COVID Update from the W.H.O.
Apr 14
•
TACT
34
Share this post
T.A.C.T.
COVID Variant Update: LP.8.1 Dominates for Now—But the Next Variant Wave Is Building. A Deep Dive into NB.1.8.1
Copy link
Facebook
Email
Notes
More
3
March 2025
Measles Alert: Potential Exposure Sites in Virginia, D.C., and Maryland
Health officials have reported 5 sites in at least nine separate instances of potential measles exposure in the region.
Mar 24
•
TACT
9
Share this post
T.A.C.T.
Measles Alert: Potential Exposure Sites in Virginia, D.C., and Maryland
Copy link
Facebook
Email
Notes
More
5
February 2025
Mysterious Ebola like illness in the Congo. Tests have ruled out Ebola and Marburg virus.
The impact of dramatic staff cuts at the CDC.
Feb 28
•
TACT
20
Share this post
T.A.C.T.
Mysterious Ebola like illness in the Congo. Tests have ruled out Ebola and Marburg virus.
Copy link
Facebook
Email
Notes
More
The Iron Side: How SARS-CoV-2 Hijacks Immune Cells and Others Without ACE2 Receptors.
As the world grapples with the ongoing challenges posed by the COVID-19 pandemic, scientists continue to unravel the mysteries of SARS-CoV-2, the virus…
Feb 15
•
TACT
2
Share this post
T.A.C.T.
The Iron Side: How SARS-CoV-2 Hijacks Immune Cells and Others Without ACE2 Receptors.
Copy link
Facebook
Email
Notes
More
January 2025
COVID Update- LP.8.1’s Rapid Growth and Its Impact on the U.S. This Winter and Spring. An Overview of What Else is Spreading
Jan 11
•
TACT
20
Share this post
T.A.C.T.
COVID Update- LP.8.1’s Rapid Growth and Its Impact on the U.S. This Winter and Spring. An Overview of What Else is Spreading
Copy link
Facebook
Email
Notes
More
6
December 2024
Long COVID in Children: Compromised Immunity and Diminished Quality of Life
The Role of Neutrophils in Lingering COVID Symptoms and Immune Dysfunction
Dec 5, 2024
•
TACT
13
Share this post
T.A.C.T.
Long COVID in Children: Compromised Immunity and Diminished Quality of Life
Copy link
Facebook
Email
Notes
More
2
How Dual Antivirals Succeeded Where Monotherapy Failed: Treating Persistent COVID-19 After Five Rounds of Resistance
The Importance of Monitoring Viral Evolution. A review of a case report published in November 2024
Dec 5, 2024
•
TACT
9
Share this post
T.A.C.T.
How Dual Antivirals Succeeded Where Monotherapy Failed: Treating Persistent COVID-19 After Five Rounds of Resistance
Copy link
Facebook
Email
Notes
More
November 2024
How the XEC Variant Pushes the Boundaries of Immune Evasion—and What It Means for Our Health
SARS-CoV-2, the virus behind COVID-19, is not done with us.
Nov 27, 2024
•
TACT
27
Share this post
T.A.C.T.
How the XEC Variant Pushes the Boundaries of Immune Evasion—and What It Means for Our Health
Copy link
Facebook
Email
Notes
More
2
Health Warning: Bird Flu Detected in Raw Milk from Fresno Dairy
Voluntary recall at the state’s request with a Best By date of 11/27/2024.
Nov 25, 2024
•
TACT
17
Share this post
T.A.C.T.
Health Warning: Bird Flu Detected in Raw Milk from Fresno Dairy
Copy link
Facebook
Email
Notes
More
12
October 2024
XEK ( XEC and KP.2.3 Recombinant Variant)
XEK ( XEC and KP.2.3 Recombinant Variant)
Oct 5, 2024
•
TACT
22
Share this post
T.A.C.T.
XEK ( XEC and KP.2.3 Recombinant Variant)
Copy link
Facebook
Email
Notes
More
4
Share
Copy link
Facebook
Email
Notes
More
This site requires JavaScript to run correctly. Please
turn on JavaScript
or unblock scripts